Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing 101 - 125 of 267
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Collecting and Storing Tissue Samples From Rare or Cutaneous

Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
Mar 23, 2022

Mantle Cell Lymphoma Trial in Canada (Acalabrutinib, R-CHOP chemo)

Recruiting
  • Mantle Cell Lymphoma
  • Vancouver, British Columbia, Canada
  • +3 more
Mar 17, 2022

Mantle Cell Lymphoma Trial in Belgium, France (Ibrutinib 560 mg, Venetoclax 10 MG Oral Tablet [Venclexta], Venetoclax 50 MG Oral

Recruiting
  • Mantle Cell Lymphoma
  • Ibrutinib 560 mg
  • +3 more
  • Bruges, Belgium
  • +39 more
Mar 3, 2022

Mantle Cell Lymphoma Trial in Germany, Italy, Switzerland (Ibrutinib, bortezomib)

Terminated
  • Mantle Cell Lymphoma
  • Mainz, Germany
  • +18 more
Feb 24, 2022

Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • +4 more
  • cellular immunotherapy
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)

    Recruiting
    • MCL
    • Mantle Cell Lymphoma
    • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
    • Odense, Denmark
    • +21 more
    Feb 11, 2022

    Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Lymphoma
    • BR-I (bendamustine, rituximab, ibrutinib)
    • VEN (Venetoclax)
    • Basking Ridge, New Jersey
    • +6 more
    Feb 3, 2022

    Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)

    Active, not recruiting
    Has Results
    • Mantle Cell Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 2, 2022

    Mantle Cell Lymphoma Trial in Houston (Bortezomib, Cyclophosphamide, Cytarabine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 27, 2022

    Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +9 more
    • NKX019
    • Denver, Colorado
    • +6 more
    Jan 19, 2022

    Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

    Completed
    • Mantle Cell Lymphoma
    • +6 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 18, 2022

    Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease, Mantle Cell Lymphoma Trial in Poland (Acalabrutinib 2x100 MG

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
    • Warszawa, Mazowieckie, Poland
    • +5 more
    Dec 23, 2021

    Mantle Cell Lymphoma Trial in Warszawa, Wroclaw (Obinutuzumab)

    Terminated
    • Mantle Cell Lymphoma
    • Warszawa, Poland
    • +1 more
    Dec 23, 2021

    CCND1 Positive, CCND2 Positive, CCND3 Positive Trial in Houston (drug, other, biological)

    Active, not recruiting
    • CCND1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 11, 2022

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T

    Terminated
    • Diffuse Large B Cell Lymphoma
    • +3 more
    • LUCAR-20S CAR-T cells
    • Hefei, Anhui, China
    • +2 more
    Dec 17, 2021

    Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

    Active, not recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • +3 more
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Dec 30, 2021

    High Grade B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements,

    Recruiting
    • High Grade B-Cell Lymphoma, Not Otherwise Specified
    • +4 more
    • Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX
    • R-CHOP; R-DA-EPOCH; R-HD MTX
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital
    Dec 7, 2021

    Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

    Recruiting
    • Hematologic Diseases
    • +11 more
    • Ann Arbor, Michigan
      University of Michigan Health System
    Dec 2, 2021

    Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

    Recruiting
    • Grade 1 Follicular Lymphoma
    • +7 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Dec 7, 2021

    Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

    Recruiting
    • Mantle Cell Lymphoma
    • +5 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 19, 2021

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021